VaccineCOVID-19Research activityLiving reviewScoping reviewObjective:This scoping review will summarize COVID-19 vaccine research activities and describe the extent,range,and nature of evidence in the research of COVID-19 vaccines.Methods:Following Arksey and O'Malley's framework and the methodological...
Previous studies have shown the safety of COVID-19 vaccination in patients with cardiovascular diseases including heart failure, and that COVID-19 outcomes are worse in patients with heart failure compared to those without heart failure. However, there has been little research on how vaccines work ...
vaccinepandemicregulationintellectual propertyhealth and safetyuniversal accessWill the regulation of a vaccine for COVID-19 be left in the hands of health standards administrators and research conventions or will an alliance of politicaldoi:10.2139/ssrn.3640153Tham, Benjamin...
national governments have implemented border restrictions and blocked exports of medical supplies. The large number of bilateral COVID-19 vaccine deals betweenhigh-income countriesand vaccine producers hindered the
NEW VACCINE RESEARCH Asked about whether new vaccines will be needed to tackle highly transmissible new variants, Pollock said that new vaccines may be needed to provide better protection. "Certainly, with Delta, we were still seeing high vaccine effectiveness in real world studies against the virus...
About This list is managed by React19 in partnership with Aaron Hertz -ashmedai@substack.com@ashmedaidemon and powered byCrossTx Visit the REACT19websiteand tell us what you think.
and community organizations that have been instrumental in the promotion of Covid-19 blood therapeutics – specifically convalescent plasma infusions. With the introduction of the Vaccine Eligibility Bot, along with a complementary bot they had developed for monoclonal antibody infusion, ...
antigen presenting cells. According to the country and region where the headquarters of the vaccine research and development unit is located, we divide these vaccines into two categories, including those jointly participated by multiple countries, and those independently developed by a single country. ...
To fully stop the spread of SARS-CoV-2, a vaccine is needed. New research suggests that our immune system, if stimulated correctly, is capable of generating anti-RBD antibodies that neutralize the virus. This bodes well for vaccine candidates using the spike protein to elicit immune responses....
The trivalent vaccine targets the Delta and Omicron variants alongside the original strain of COVID-19, according to the Chinese biopharmaceutical company. Preclinical studies have shown that the two vaccines are safe and effective. In the forthcoming clinical research, a multicenter, randomized, double...